Average Co-Inventor Count = 3.17
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cytlimic Inc. (8 from 8 patents)
2. Nec Corporation (7 from 35,670 patents)
3. Kochi University (4 from 50 patents)
4. Ehime University (45 patents)
15 patents:
1. 12448413 - HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
2. 11759518 - Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
3. 11618770 - MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same
4. 11491204 - Composition comprising poly I:C and LAG-3-IGG fusion protein
5. 11304997 - HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
6. 11291718 - Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
7. 10875900 - Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
8. 10842848 - Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein
9. 10590179 - Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
10. 10537626 - HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
11. 10526388 - Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
12. 9353151 - HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
13. 9045531 - HLA-binding peptide, precursor thereof, and DNA fragment and recombinant vector coding for said HLA-binding peptide
14. 8487076 - HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
15. 8324345 - HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same